Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000264021

Medchemexpress LLC Enavogliflozin | 1415472-28-4 | 98.4% | 446.92 g·mol⁻¹ | C24H27ClO6 | 5 MG
SDP

Catalog No. 5000264021
Encompass_Preferred

Enavogliflozin is an orally active, selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor developed for treatment of type 2 diabetes and related metabolic disorders. The compound is provided to researchers as a solid powder and as concentrated solution formats for in vitro and translational studies, and it has been characterized in peer-reviewed studies and regulatory entries.

Catalog No. 50-002-64021 Supplier Medchemexpress LLC Supplier No. HY1091445MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Enavogliflozin is an orally active, selective sodium-glucose cotransporter-2 (SGLT-2) inhibitor developed for treatment of type 2 diabetes and related metabolic disorders. The compound is provided to researchers as a solid powder and as concentrated solution formats for in vitro and translational studies, and it has been characterized in peer-reviewed studies and regulatory entries.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.